Document Type : Original Research


1 Dept. of Clinical Research, Pasteur Institute of Iran, Tehran, Iran

2 Gholhak Lab, Tehran, Iran

3 Iranian Society for Support Patients with Infectious Disease, Tehran, Iran

4 Iranian Research of Center for HIV/AIDS, Tehran, Iran



Background & Objective: Interleukin (IL)-10 is an important anti-inflammatory and immunomodulatory cytokine. Some authors believe that single nucleotide polymorphisms (SNP) in the promoter region of the IL-10 gene have been associated with susceptibility to HIV infection and progression to AIDS, but its role is not clearly defined yet. The present study was undertaken to evaluate the association between HIV infection susceptibility and progression with SNP in the promoter region of the IL-10 gene. Methods: This study was carried out on 70 HIV infected patients (39 treatment naïve and 31 undertreatment) and 31 matched healthy controls. The biallelic polymorphisms in the IL-10 gene promoter (-592 ,-1082) were analyzed by polymerase chain reaction and direct sequencing. Results: At position -1082, G/A was the most common genotype and A was the most prevalent allele and at position -592, A/C was the most prevalent genotype and -592 C was the most common allele in HIV positive patients; although there was not any significant difference between cases and controls regarding genotypes and alleles of these regions. Conclusion: Genetic polymorphisms of IL-10 promoter region may not associate with HIV infection outcome and the lack of this association suggests that other genes may influence on HIV infection course.


  1. UNAIDS. AIDS Epidemic Update. UNAIDS/WHO: Geneva, Switzerland, 2006.
  2. Dumont F. Therapeutic potential of IL-10 and its viral homologues: an update. Expert Opin Ther Patents 2003; 13(10): 1551-1577.
  3. Kingkeow D, McNicholl JM, Maneekarn N, Wongtrakul J, Taechareonkul S, Suriyanon V, et al.Frequencies of IL10 SNP genotypes by multiplex PCRSSP and their association with viral load and CD4 counts in HIV-1-infected Thais. Asian Pac J Allergy Immunol 2011; 29(1):94-101.
  4. Chatterjee A, Rathore A, Sivarama P, Yamamoto N, Dhole TN. Genetic association of IL10 gene promoter polymorphism and HIV1 infection in North Indians. J Clin Immunol 2009; 29(1):71-7.
  5. Mocellin S, Marincola FM, Young HA. Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol 2005;78(5):1043–51.
  6. Shrestha S, Wiener HW, Aissani B, Song W, Shendre A, Wilson CM, et al.Interleukin-10 (IL-10) pathway: genetic variants and outcomes of HIV-1 infection in African American adolescents PLoS One 2010; 5(10):e13384.
  7. Breen EC, Boscardin WJ, Detels R, Jacobson LP, Smith MW, O’Brien SJ, et al.Non-Hodgkin’s B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the IL10 promoter -592 C/C genotype. Clin Immunol 2003;109:119-29.
  8. Brooks  DG,  Trifilo  MJ,  Edelmann  KH,  Teyton L, McGavern DB, Oldstone MB. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med. 2006;12(11):1301-9.
  9. Brockman MA, Kwon DS, Tighe DP, Pavlik DF, Rosato PC, Sela J, et al.IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood 2009;114(2):346-56.
  10. Elrefaei M, Barugahare B, Ssali F, Mugyenyi P, Cao H. HIV-Specific IL-10-Positive CD8+ T Cells Are Increased in Advanced Disease and Are Associated with Decreased  HIV-Specific  Cytolysis.  J  Immunol  2006; 15;176(2):1274-80.
  11. Ostrowski MA, Gu JX, Kovacs C, Freedman J, Luscher MA, MacDonald KS. Quantitative and qualitative  assessment  of  human  immunodeficiency virus  type  1  (HIV-1)-specific  CD4+  T  cell  immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses. J Infect Dis 2001; 15;184(10):1268-78.
  12. Badou A, Bennasser Y, Moreau M, Leclerc C, Benkirane M, Bahraoui E. Tat protein of human immunodeficiency  virus  type  1  induces  interleukin-10 in human peripheral blood monocytes: implication of protein kinase C-dependent pathway. J Virol 2000; 74(22):10551-62.
  13. Naicker DD, Werner L, Kormuth E, Passmore JA, Mlisana K, Karim SA, et al.Interleukin-10 promoter polymorphisms  influence  HIV-1  susceptibility and primary HIV-pathogenesis J Infect Dis 2009; 200(3):448-52.
  14. Erikstrup C, Kallestrup P, Zinyama-Gutsire RB, Gomo E, Butterworth AE, Pedersen BK, Ostrowski SR, Gerstoft J, Ullum H. reduced mortality and CD4 cell loss among carriers ofthe interleukin-10 -1082G allele in a Zimbabwean cohort of HIV-1-infected adults. AIDS 2007; 21(17):2283-91.
  15. Shin HD, Winkler C, Stephens JC, Bream J, Young H, Goedert JJ, et al.Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci U S A 2000;97(26):14467-72.
  16. Oleksyk TK, Shrestha S, Truelove AL, Goedert JJ, Donfield SM, Phair J, et al. Extended IL10 haplotypes and their association with HIV progression to AIDS. Genes Immun 2009;10(4):309-22.
  17. Wang S, Huang D, Sun S, Ma W, Zhen Q. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis B to interferon alfa. Virol J 2011; 8(1):28.
  18. Sobti RC, Berhane N, Mahedi SA, Kler R, Hosseini SA, Kuttiat V, Wanchu A. Polymorphisms of IL-6 174 G/C, IL-10 -592 C/A and risk of HIV/AIDS among North Indian population. Mol Cell Biochem 2010;337(1-2):145-52.
  19. Lu YL, Wu X, Huang HL, Dai LC. Allele polymorphisms of interleukin-10 and hepatitis B, C virus infection. Chin Med J (Engl) 2010; 123(10):1338-44.
  20. Murray PJ, Wang L, Onufryk C, Tepper RI, Young RA. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol 1997; 158(1):315-21.
  21. Llorente L, Richaud-Patin Y, Fior R, Alcocer-Varela J, Wijdenes J, Fourrier BM, et al.In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren’s syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthr Rheum 1994; 37(11):1647-55.
  22. Mason D, Powrie F. Control of immune pathology by regulatory T cells. Curr Opin Immunol 1998; 10(6):649-55.
  23. Fortis C, Foppoli M, Gianotti L, Galli L, Citterio G, Consogno G, et al.Increased interleukin-10 serum levels in patients with solid tumours. Cancer Lett 1996; 104(1):1-5.
  24. Soufian  S, Aghakhani A,  Mohraz  M,  Banifazl  M, Eslamifar A, Boland-Ghamat Z, et al.No evidence of the Th1 to Th2 cytokine shift during the course of HIV infection. Iran J Pathol 2012 ;7(2):88-93.